Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
Pathogenetic Justification and Clinical and Immunological Efficiency of Application Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
Sponsor: Mikhael Petrovich Kostinov
Listed as NCT02787863, this PHASE4 trial focuses on Asthma and Chronic Obstructive Pulmonary Disease and remains completed. Sponsored by Mikhael Petrovich Kostinov, it has been updated 9 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Mar 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Jan 2020 — Mar 2020 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Recruiting PHASE4
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mikhael Petrovich Kostinov
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .